Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome

Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. https://t.co/nDa5KxHNGf

Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. https://t.co/JTkbc8qUZI

Short-course rifaximin therapy efficacy and lactulose hydrogen breath test in chinese patients with diarrhea-predominant ir... - Zhuang X et al. - https://t.co/MSv9NDeTJG #microbiome